C13H13N3O3
259.26 g/mol
APIDanger
Lenalidomide
CAS191732-72-6EC691-297-1
Category
API
Compound Class
Amide
Primary Use
Pharmaceutical Raw Material
Lenalidomide is a dicarboximide compound that inhibits the secretion of TNF-alpha and acts as an antineoplastic agent, an angiogenesis inhibitor, and an immunomodulator. It is used as an active pharmaceutical ingredient in pharmaceutical manufacturing.
antineoplastic agentangiogenesis inhibitorimmunomodulator
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 191732-72-6
Related Compounds
ReferenceSame Category
6,7-dimethoxy-2-N,2-N-dimethylquinazoline-2,4-diamine
CAS19216-53-6
pharmaceutical raw material
ReferenceSame Category
Prazosin
CAS19216-56-9
pharmaceutical raw material
ReferenceSame Category
Prazosin hydrochloride
CAS19237-84-4
pharmaceutical raw material
ReferenceSame Category
Linrodostat
CAS1923833-60-6
pharmaceutical raw material
Referencesame scaffold
3-(4-Nitro-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione
CAS827026-45-9
pharmaceutical intermediate
Safety Reference
Danger
H301Toxic if swallowed
H302Harmful if swallowed
H312Harmful in contact with skin
H332Harmful if inhaled
H360May damage fertility or the unborn child
H372Causes damage to organs through prolonged or repeated exposure
Identifiers
IUPAC Name
3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione
InChIKey
GOTYRUGSSMKFNF-UHFFFAOYSA-N
SMILES
C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N
Synonyms (30)
- Lenalidomide (JAN/USAN/INN)
- ENMD 0997
- IMiD3 cpd
- LENALIDOMIDE [MART.]
- Lenadoamide
- Lenalidomida
- Lenalidomide
- Lenalidomide (CC-5013)
- Lenalidomide (Standard)
- Revimid
- Revlimid
- Revlimid (TN)
- Revlimid (TN) (Celgene)
- lenalidomidum